Swiss Analysis of Multiple Sclerosis: A Multicenter, Non-Interventional, Retrospective Cohort Study of Disease-Modifying Therapies

Publisher： Karger

E-ISSN： 1421-9913|70|1-2|35-41

ISSN： 0014-3022

Source： European Neurology, Vol.70, Iss.1-2, 2013-05, pp. : 35-41

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Efficacy of Disease-Modifying Therapies in Relapsing Remitting Multiple Sclerosis: A Systematic Comparison

By  

European Neurology, Vol. 60, Iss. 1, 2008-04 ,pp. : 1-11

Karger

Access to resources Recommend Favorite

Nabiximols (THC/CBD Oromucosal Spray, Sativex®) in Clinical Practice - Results of a Multicenter, Non-Interventional Study (MOVE 2) in Patients with Multiple Sclerosis Spasticity

By  

European Neurology, Vol. 71, Iss. 5-6, 2014-02 ,pp. : 271-279

Karger

Access to resources Recommend Favorite

Adherence to Disease-Modifying Therapies in Spanish Patients with Relapsing Multiple Sclerosis: Two-Year Interim Results of the Global Adherence Project

By  

European Neurology, Vol. 65, Iss. 2, 2011-01 ,pp. : 59-67

Karger

Access to resources Recommend Favorite

Disease-Modifying Therapies and Adherence in Multiple Sclerosis: Comparing Patient Self-Report with Pharmacy Records

By  

Neuroepidemiology, Vol. 48, Iss. 3-4, 2017-07 ,pp. : 124-130

Karger

Access to resources Recommend Favorite

Retrospective Cohort Study of Gender Differential in Risk of Multiple Sclerosis in Kuwait

By  

Neuroepidemiology, Vol. 46, Iss. 3, 2016-02 ,pp. : 203-208

Karger

Access to resources Recommend Favorite